- Record: found
- Abstract: found
- Article: not found
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
K Budde
1 ,
J L Bosmans ,
J Sennesael ,
M Zeier ,
P Pisarski ,
M Schütz ,
W Fischer ,
H H Neumayer ,
P Glander
Mar 2007
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The lower limit of exposure to calcineurin inhibitors has not yet been established in de novo renal transplant patients receiving mycophenolic acid therapy with basiliximab.